Insiders Trades

★ Sign in to follow

WJ

William James Garner

Tryp Therapeutics Inc.

Cumul. flow

Total declarations

21

Company

1

▲ Purchases (21 ops.)

€2.9M

▼ Sales (0 ops.)

—

Latest filing published 25 Apr 2022 for Tryp Therapeutics Inc., €2.2M.

Filing timeline

BuySale

William James Garner

Insider track record

Disclosed buys

21

Disclosed sells

0

Signal history

William James Garner: trading record in brief

William James Garner is a declared insider of Tryp Therapeutics Inc., with filings sourced from SEDI. Over a trading history stretching from 28 January 2021 to 22 April 2022, the count stands at 21 filings.

No open-market sale appears; the market trades are 21 purchases worth €2.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings 2 purchases and no sales.

The median purchase comes to €2,370. No cluster: in 21 purchases, no other insider of the company bought within 30 days.

On 25 April 2022 came the latest disclosure, an open-market purchase for €2.2M in Tryp Therapeutics Inc. Filings reach the SEDI feed a median of 1 day after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.

Companies and markets linked to William James Garner

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Tryp Therapeutics Inc. (CA)

Declarations21 total

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives22 Apr 2022Tryp Therapeutics Inc.

3M CAD18SEDI

20,000,000 shares@ CA$0.1574.7% of flowCommon SharesTSXSEDI:3935624

Canonical exit: 21 Jul 2022 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives22 Feb 2022Tryp Therapeutics Inc.

1M CAD19SEDI

5,000,000 shares@ CA$0.2093.0% of flowCommon SharesTSXSEDI:3888966

Canonical exit: 23 May 2022 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives26 Oct 2021Tryp Therapeutics Inc.

5,730 CAD15SEDI

20,000 shares@ CA$0.286578.9% of flowCommon SharesTSXSEDI:3822084

Canonical exit: 24 Jan 2022 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Oct 2021Tryp Therapeutics Inc.

1,534 CAD7SEDI

5,000 shares@ CA$0.306821.1% of flowCommon SharesTSXSEDI:3822252

Canonical exit: 23 Jan 2022 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

926 CAD11SEDI

2,500 shares@ CA$0.37041.3% of flowCommon SharesTSXSEDI:3794511

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

3,509 CAD5SEDI

10,000 shares@ CA$0.35094.8% of flowCommon SharesTSXSEDI:3794504

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

930 CAD11SEDI

2,500 shares@ CA$0.3721.3% of flowCommon SharesTSXSEDI:3794510

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

540 CAD11SEDI

1,500 shares@ CA$0.360.7% of flowCommon SharesTSXSEDI:3794515

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

1,572 CAD5SEDI

4,500 shares@ CA$0.34932.2% of flowCommon SharesTSXSEDI:3794505

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

10,473 CAD6SEDI

30,000 shares@ CA$0.349114.4% of flowCommon SharesTSXSEDI:3794501

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

11,640 CAD7SEDI

34,500 shares@ CA$0.337416.0% of flowCommon SharesTSXSEDI:3794502

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

6,372 CAD12SEDI

17,500 shares@ CA$0.36418.7% of flowCommon SharesTSXSEDI:3794512

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

10,517 CAD12SEDI

28,500 shares@ CA$0.36914.4% of flowCommon SharesTSXSEDI:3794516

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

900 CAD11SEDI

2,500 shares@ CA$0.36011.2% of flowCommon SharesTSXSEDI:3794513

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

9,109 CAD6SEDI

25,500 shares@ CA$0.357212.5% of flowCommon SharesTSXSEDI:3794503

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

356 CAD11SEDI

1,000 shares@ CA$0.35620.5% of flowCommon SharesTSXSEDI:3794514

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

352 CAD5SEDI

1,000 shares@ CA$0.35220.5% of flowCommon SharesTSXSEDI:3794506

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

1,553 CAD5SEDI

4,500 shares@ CA$0.34512.1% of flowCommon SharesTSXSEDI:3794508

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives25 Aug 2021Tryp Therapeutics Inc.

1,560 CAD11SEDI

4,000 shares@ CA$0.392.1% of flowCommon SharesTSXSEDI:3794509

Canonical exit: 23 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives24 Aug 2021Tryp Therapeutics Inc.

5,052 CAD6SEDI

14,500 shares@ CA$0.34846.9% of flowCommon SharesTSXSEDI:3794507

Canonical exit: 22 Nov 2021 (T+90)

▲

William James Garner

3 - 10% Security Holder of IssuerExecutives28 Jan 2021Tryp Therapeutics Inc.

4,974 CAD6SEDI

10,500 shares@ CA$0.47376.1% of flowCommon SharesTSXSEDI:3669677

Canonical exit: 28 Apr 2021 (T+90)

21 of 21 declarations